Publication | Closed Access

Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST)

Surgical OncologyGastrointestinal OncologyMedicineGastroenterologySurgeryResectable Gastric AdenocarcinomaPerioperative RegimenCancer TreatmentOncologyRadiation OncologyCancer Research